Published • loading... • Updated
Sun Life finds single leukemia claim neared $8M as $1M+ bills surge
Blood cancers drove the highest multimillion-dollar claims, and GLP-1-related claims rose 24% as comorbidities and long hospital stays pushed costs higher.
- On Thursday, Sun Life released its annual High-Cost Claims and Injectable Drug Trends report, revealing that million-dollar medical claims increased in frequency by 46% between 2022 and 2026.
- Secondary health conditions, long hospitalizations, and specialized injectable drugs are the primary drivers of claims exceeding $3 million, according to the report.
- Blood cancers averaged $5.45 million in 2025, with one leukemia patient claim reaching nearly $8 million; Elevidys gene therapy averaged $3.6 million.
- Claims involving GLP-1s increased 24% over the past year, while orthopedic conditions have recently reached million-dollar levels, suggesting rising treatment severity.
- Jennifer Collier, president of Health and Risk Solutions at Sun Life, stated, "We have a real opportunity to help people achieve meaningful, improved health outcomes by prioritizing whole-person care.
Insights by Ground AI
32 Articles
32 Articles
Bennington Banner+30 Reposted by 30 other sources
What drives multimillion-dollar medical claims? Sun Life report shows secondary health conditions, hospital stays and specialty drugs among key factors
WELLESLEY, Mass., May 21, 2026 /PRNewswire/ -- Sun Life U.S. has released its annual High-Cost Claims and Injectable Drug Trends report, which analyzed over 70,000 high-dollar medical claims from more than 3,300 self-funded employers across the country. This year's report…
Coverage Details
Total News Sources32
Leaning Left5Leaning Right2Center13Last UpdatedBias Distribution65% Center
Bias Distribution
- 65% of the sources are Center
65% Center
L 25%
C 65%
Factuality
To view factuality data please Upgrade to Premium
